A breakthrough in cancer diagnosis has been achieved through the development of a non-invasive, early detection material technology based on bio-fluids. Led by Dr. Ho Sang Jung of the Korea Institute of Materials Science (KIMS), a research team has created an innovative sensor material that amplifies optical signals of cancer metabolites in body fluids, such as saliva, mucus, and urine, and analyzes them using artificial intelligence to diagnose cancer. This technology can quickly and sensitively detect metabolite changes in cancer patients' body fluids, providing a non-invasive way to diagnose cancer without traditional blood draws or biopsies. Collaborating with Professor Soo Woong Yoo of Chonnam National University Hospital, the team successfully diagnosed colorectal cancer using a plasmonic needle that amplifies Raman signals of molecules. Additionally, they developed a technology that collects saliva from lung cancer patients and categorizes the cancer's stage in collaboration with Professor Byung-Ho Chung at Samsung Medical Center. The research has been recognized for its excellence, with three papers published in leading scientific journals and 10 patents filed in Korea, the U.S., and Europe.
↧